PFO
MJN

Pathstone Family Office’s Mead Johnson Nutrition Company MJN Stock Holding History

Pathstone Family Office’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11
Closed -$1K – 715
2017
Q1 		$1K Buy
+11
New +$905 ﹤0.01% 561
2013
Q4 		– Sell
-31
Closed -$2K – 361
2013
Q3 		$2K Buy
+31
New +$2.32K 0.01% 287

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Pathstone Family Office's MJN Position: Q2 2017 in Review

Pathstone Family Office sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 11 shares — an estimated $1K sold.

Pathstone Family Office first reported a position in MJN in Q3 2013 and held it in 2 quarters. The position peaked at $2K in Q3 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Pathstone Family Office reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Pathstone Family Office sold 11 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1K.
  • Pathstone Family Office first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 2 quarters.
  • Pathstone Family Office's Mead Johnson Nutrition Company position peaked at $2K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.